Efficacy and Safety of the Anti-COVID-19 Antibody SA55 for Injection in Patients With Hematological Disorders Who Are Persistently Positive for COVID-19
Clinical trial NCT05675943 · COMPLETED
Trial details
- NCT number
- NCT05675943
- Sponsor
- Beijing Boren Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-12
- Primary completion
- 2024-04-03
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.